PHARMAIDS PHARMACEUTICALS LTD.
BSE: 524572
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 2.69+222.9% | 0.83-86.0% | 5.97+434.9% | 1.12+741.7% | 0.13-89.0% | 1.21+44.8% | 0.83 |
| Other Income | 0.06+1.1% | 0.06-68.0% | 0.19-45.1% | 0.35-65.5% | 1.01+25070.0% | 0.00-20.0% | 0.01 |
| Total Income | 2.75+207.8% | 0.89-85.5% | 6.16+320.9% | 1.46+28.4% | 1.14-6.0% | 1.21+44.5% | 0.84 |
| EXPENSES | |||||||
| Expenditure | 4.42-13.8% | 5.13-55.8% | 11.62+62.4% | 7.15+45.4% | 4.92+61.0% | 3.06+50.9% | 2.03 |
| Tax | -0.38+66.4% | -1.13-65.5% | -0.68+48.7% | -1.33-83.3% | -0.72-387.6% | 0.25+40.0% | 0.18 |
| PROFIT | |||||||
| PBT | -1.69+60.1% | -4.24-81.6% | -2.33+59.0% | -5.69-50.5% | -3.78-104.9% | -1.84-55.4% | -1.19 |
| Net Profit | -1.31+57.8% | -3.11-88.2% | -1.65+62.1% | -4.36-42.7% | -3.06-91.9% | -1.59-58.2% | -1.01 |
| KEY METRICS | |||||||
| OPM % | -40.91%+59.09pp | -100.00%-75.72pp | -24.28%+75.72pp | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -47.70%+52.30pp | -100.00%-73.16pp | -26.84%+73.16pp | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | 0.37-58.0% | 0.88+87.2% | 0.47-62.1% | 1.24+44.2% | 0.86+291.1% | -0.45-55.2% | -0.29 |
Corporate Events
Board MeetingPHARMAID
202629May
Board Meeting
The board meeting is scheduled to consider and approve the A…
BSE Filing ↗ Board MeetingPHARMAID
20254Jul
Board Meeting
Disinvestment/Sale/Disposal of the entire Partnership stake …
BSE Filing ↗ Board MeetingPHARMAID
202413Nov
Board Meeting
Consideration and approval of the unaudited financial result…
BSE Filing ↗ Board MeetingPHARMAID
202428Aug
Board Meeting
Considering and approving the Audited Financial Statements (…
BSE Filing ↗ Board MeetingPHARMAID
202413Aug
Board Meeting
Consider and approve the Unaudited Financial Results for the…
BSE Filing ↗ Board MeetingPHARMAID
202412Feb
Board Meeting
Consider and approve the unaudited financial results (Standa…
BSE Filing ↗ Board MeetingPHARMAID
202311Nov
Board Meeting
Consider and approve Unaudited Financial Results (Standalone…
BSE Filing ↗ Board MeetingPHARMAID
202329Aug
Board Meeting
Consider and approve the Audited Financial Statements (Stand…
BSE Filing ↗